Abstract
Eighteen patients with endometriosis or uterine myoma underwent MRI before and after conservative treatment with Danazol (400 mg/day) or Buserelin (900 {mu}g/day) to examine pathological changes. Of 8 patients with endometrial chocolate cyst, 7 patients were given Dazazol for 3 to 7 months, in whom high signal intensity indicative of mass tended to decrease after chemotherapy especially on T2-weighted images. In addition, the area of cyst was reduced by 31% to 100%. In the remaining one patient receiving Buserelin for 8 months, the reduction rate of cyst was 31%. Ten patients with adenomyosis were classified into the group given Danazol for 5 to 15 months (n=4) and the group given Buserelin for 3 to 8 months (n=6). Low intensity area was decreased by 9% to 25% in the Danazol group and by 20% to 69% in the Buserelin group. Uterine area was reduced by 10% to 32% in the Danazol group and by 4.5% to 51% in the Buserelin group. MRI was helpful in the management of these diseases during conservative treatment. (N.K.).
Kasai, Mayumi;
Karibe, Akihiko;
Sato, Ken;
Suzuki, Hirosi;
Iida, Hajime;
[1]
Yamaya, Rie
- Iwate Prefectural Central Hospital, Morioka (Japan)
Citation Formats
Kasai, Mayumi, Karibe, Akihiko, Sato, Ken, Suzuki, Hirosi, Iida, Hajime, and Yamaya, Rie.
MRI evaluation for conservative treatment in endometriosis and uterine myoma.
Japan: N. p.,
1991.
Web.
Kasai, Mayumi, Karibe, Akihiko, Sato, Ken, Suzuki, Hirosi, Iida, Hajime, & Yamaya, Rie.
MRI evaluation for conservative treatment in endometriosis and uterine myoma.
Japan.
Kasai, Mayumi, Karibe, Akihiko, Sato, Ken, Suzuki, Hirosi, Iida, Hajime, and Yamaya, Rie.
1991.
"MRI evaluation for conservative treatment in endometriosis and uterine myoma."
Japan.
@misc{etde_6201273,
title = {MRI evaluation for conservative treatment in endometriosis and uterine myoma}
author = {Kasai, Mayumi, Karibe, Akihiko, Sato, Ken, Suzuki, Hirosi, Iida, Hajime, and Yamaya, Rie}
abstractNote = {Eighteen patients with endometriosis or uterine myoma underwent MRI before and after conservative treatment with Danazol (400 mg/day) or Buserelin (900 {mu}g/day) to examine pathological changes. Of 8 patients with endometrial chocolate cyst, 7 patients were given Dazazol for 3 to 7 months, in whom high signal intensity indicative of mass tended to decrease after chemotherapy especially on T2-weighted images. In addition, the area of cyst was reduced by 31% to 100%. In the remaining one patient receiving Buserelin for 8 months, the reduction rate of cyst was 31%. Ten patients with adenomyosis were classified into the group given Danazol for 5 to 15 months (n=4) and the group given Buserelin for 3 to 8 months (n=6). Low intensity area was decreased by 9% to 25% in the Danazol group and by 20% to 69% in the Buserelin group. Uterine area was reduced by 10% to 32% in the Danazol group and by 4.5% to 51% in the Buserelin group. MRI was helpful in the management of these diseases during conservative treatment. (N.K.).}
journal = []
volume = {40:7}
journal type = {AC}
place = {Japan}
year = {1991}
month = {Jul}
}
title = {MRI evaluation for conservative treatment in endometriosis and uterine myoma}
author = {Kasai, Mayumi, Karibe, Akihiko, Sato, Ken, Suzuki, Hirosi, Iida, Hajime, and Yamaya, Rie}
abstractNote = {Eighteen patients with endometriosis or uterine myoma underwent MRI before and after conservative treatment with Danazol (400 mg/day) or Buserelin (900 {mu}g/day) to examine pathological changes. Of 8 patients with endometrial chocolate cyst, 7 patients were given Dazazol for 3 to 7 months, in whom high signal intensity indicative of mass tended to decrease after chemotherapy especially on T2-weighted images. In addition, the area of cyst was reduced by 31% to 100%. In the remaining one patient receiving Buserelin for 8 months, the reduction rate of cyst was 31%. Ten patients with adenomyosis were classified into the group given Danazol for 5 to 15 months (n=4) and the group given Buserelin for 3 to 8 months (n=6). Low intensity area was decreased by 9% to 25% in the Danazol group and by 20% to 69% in the Buserelin group. Uterine area was reduced by 10% to 32% in the Danazol group and by 4.5% to 51% in the Buserelin group. MRI was helpful in the management of these diseases during conservative treatment. (N.K.).}
journal = []
volume = {40:7}
journal type = {AC}
place = {Japan}
year = {1991}
month = {Jul}
}